胎儿多普勒测速、胎儿生长轨迹及母体血清生物标志物对短期不良围产结局的预测价值:DRIGITAT研究的二次分析
该研究为DRIGITAT研究的预设事后分析,纳入440例32.0-36.9周单胎小于胎龄儿(SGA)孕妇,评估胎盘功能不全和胎儿生长受限标志物对复合不良围产结局(CAPO)的预测价值。结果显示,纳入时估计胎儿体重(EFW)、可溶性fms样酪氨酸激酶-1与胎盘生长因子比值(sFlt-1/PlGF比值)及孕期最高脐脑比值(UCR)组成的预测模型AUC为0.75(95%CI 0.70-0.81);假阳性率5%、10%、25%时敏感度分别为35.6%、44.2%、63.5%。
要点
- 在SGA人群中,纳入时EFW、sFlt-1/PlGF比值和孕期最高UCR组成的模型对CAPO预测AUC为0.75(95%CI 0.70-0.81)。
- 假阳性率5%、10%、25%时,该模型预测CAPO的敏感度分别为35.6%、44.2%、63.5%。
- 发生CAPO的新生儿分娩孕周和出生体重均低于未发生者(37.0周 vs 38.3周;1.993 kg vs 2.518 kg)。
核心结论
- 在SGA人群中,纳入时母体BMI、孕周、EFW、sFlt-1/PlGF比值、孕期最高UCR、子痫前期发生及胎儿生长速度均与CAPO显著相关;包含纳入时EFW、纳入时sFlt-1/PlGF比值和最高UCR的模型对CAPO预测最有效。
研究设计与样本
- DRIGITAT研究的预设事后分析,荷兰多中心队列研究,纳入2018至2022年间690例32.0-36.9周单胎SGA孕妇,本分析使用其中440例有生物标志物测量且未因反复多普勒测速异常而在36周前随机立即分娩者的数据。
诊断标准与关键数值
- 最终预测模型(纳入时EFW、纳入时sFlt-1/PlGF比值、孕期最高UCR)预测CAPO的AUC为0.75(95%CI 0.70-0.81);假阳性率5%、10%、25%时敏感度分别为35.6%、44.2%、63.5%。
临床应用与阅片要点
- 作者采用前向逐步逻辑回归建立预测模型以模拟真实世界临床评估;原文未据此给出推荐。
局限性
- 本文为预设事后分析,仅纳入440例有生物标志物测量且未随机立即分娩的参与者。
- 预测模型AUC为0.75(95%CI 0.70-0.81),假阳性率5%时敏感度仅35.6%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the predictive value of markers of placental insufficiency and fetal growth restriction for a composite adverse perinatal outcome (CAPO) in a small-for-gestational-age (SGA) population. We also aimed to identify profiles that discriminate fetuses as low or high risk for CAPO, and to evaluate the association of onset of labor and mode of birth with CAPO.
METHODS: This was a preplanned post-hoc analysis of the DRIGITAT study, a Dutch multicenter cohort study of management strategy in 690 singleton SGA pregnancies at 32.0-36.9 weeks' gestation, between 2018 and 2022. We used data from 440 participants with available biomarker measurements, who were not randomized for immediate birth before 36 weeks' gestation on the basis of recurrent abnormal Doppler velocimetry. We defined CAPO as fetal death, adverse condition at birth, major neonatal morbidity and/or neonatal mortality. We analyzed the predictive value for CAPO of maternal body mass index (BMI), gestational age, estimated fetal weight (EFW) and soluble fms-like tyrosine kinase-1 to placental growth factor ratio (sFlt-1/PlGF ratio) at inclusion, development of pre-eclampsia, highest value of the umbilicocerebral ratio (UCR) and fetal growth velocity. We also used these variables to develop a prediction model for CAPO using forward stepwise logistic regression to emulate real-world clinical evaluation.
RESULTS: In this population of 440 singleton SGA pregnancies, maternal BMI at inclusion (P = 0.02), gestational age at inclusion (P ≤ 0.001), EFW at inclusion (P ≤ 0.001), sFlt-1/PlGF ratio at inclusion (P ≤ 0.001), development of pre-eclampsia (P ≤ 0.001), highest value of the UCR measured at any time during pregnancy (P ≤ 0.001) and fetal growth velocity (P ≤ 0.001) were all associated significantly with CAPO. When combined into a prediction model using logistic regression analysis, maternal BMI at inclusion, gestational age at inclusion, development of pre-eclampsia and fetal growth velocity did not add to the predictive value of the model, because of their correlation with other variables. The area under the receiver-operating-characteristics curve of the final prediction model, comprising EFW at inclusion, sFlt-1/PlGF ratio at inclusion and the highest UCR value at any time, was 0.75 (95% CI, 0.70-0.81). At false-positive rates of 5%, 10% and 25%, the sensitivities of the prediction model for CAPO were 35.6%, 44.2% and 63.5%, respectively. The median gestational age at birth and birth weight were lower in neonates that experienced CAPO compared with those that did not (37.0 weeks vs 38.3 weeks and 1.993 kg vs 2.518 kg, respectively). Vaginal birth occurred in 69.3% of our population. In the group that experienced CAPO, a higher number of (emergency) Cesarean sections were performed.
CONCLUSIONS: In a SGA population, maternal BMI, gestational age, EFW and sFlt-1/PlGF ratio at inclusion, highest UCR at any time, development of pre-eclampsia and fetal growth velocity were associated with CAPO. A model incorporating EFW at inclusion, sFlt-1/PlGF ratio at inclusion and highest UCR was most effective for the prediction of CAPO. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Kamphof HD, Marijnen MC, Damhuis SE, et al. Predictive value of fetal Doppler velocimetry, fetal growth trajectory and maternal serum biomarkers for short-term adverse perinatal outcome: secondary analysis of DRIGITAT study. Ultrasound Obstet Gynecol. 2025. PMID: 40641303. doi:10.1002/uog.29266
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。